CYTOMX THERAPEUTICS, INC.
Patent Owner
Stats
- 26 US PATENTS IN FORCE
- 8 US APPLICATIONS PENDING
- Feb 13, 2018 most recent publication
Details
- 26 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 2,220 Total Citation Count
- Oct 09, 2001 Earliest Filing
- 4 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0072,067 COMPOSITIONS AND METHODS FOR CONJUGATING ACTIVATABLE ANTIBODIESNov 22, 16Mar 16, 17[A61K, C07K]
2017/0002,082 ACTIVATABLE ANTIBODIES THAT BIND INTERLEUKIN-6 RECEPTOR AND METHODS OF USE THEREOFSep 21, 16Jan 05, 17[C07K]
2016/0264,961 PROTEASE-RESISTANT SYSTEMS FOR POLYPEPTIDE DISPLAY AND METHODS OF MAKING AND USING THEREOFMar 28, 16Sep 15, 16[C12N, C07K]
2016/0194,399 ANTI-CD3 ANTIBODIES, ACTIVATABLE ANTI-CD3 ANTIBODIES, MULTISPECIFIC ANTI-CD3 ANTIBODIES, MULTISPECIFIC ACTIVATABLE ANTI-CD3 ANTIBODIES, AND METHODS OF USING THE SAMEJul 24, 15Jul 07, 16[A61K, C07K]
2015/0087,810 Matrix Metalloproteinase Substrates And Other Cleavable Moieties And Methods Of Use ThereofSep 25, 14Mar 26, 15[C07K]
2015/0079,088 MULTISPECIFIC ANTIBODIES, MULTISPECIFIC ACTIVATABLE ANTIBODIES AND METHODS OF USING THE SAMEJul 25, 14Mar 19, 15[C07K]
2014/0023,664 Activatable Antibodies Having Non-Binding Steric Moieties and Methods of Using the SameJun 21, 13Jan 23, 14[C07K]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9889211 Activatable antibodies that bind epidermal growth factor receptor and methods of use thereofDec 16, 16Feb 13, 18[A61K, G01N]
9856314 Activatable antibodies having non-binding steric moieties and methods of using the sameJun 21, 13Jan 02, 18[A61K, G01N, C07K]
9737623 Antibodies that bind activatable antibodies and methods of use thereofDec 11, 14Aug 22, 17[A61K, G01N, C07K]
9695249 Antibodies specific for urokinase-type plasminogen activator and methods of use thereofDec 17, 15Jul 04, 17[A61K, C07K]
9688748 Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and methods of use thereofJul 31, 15Jun 27, 17[A61K, C12P, C07K]
9644016 Soluble notch receptor proproteins and methods of use thereofMar 30, 15May 09, 17[A61K, G01N, C07K]
9562073 Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereofJan 30, 15Feb 07, 17[A61K, C07K]
9545442 Activatable antibodies that bind epidermal growth factor receptor and methods of use thereofJul 31, 15Jan 17, 17[A61K, C12P, G01N, C07K]
9540440 Activatable antibodies that bind epidermal growth factor receptor and methods of use thereofOct 30, 14Jan 10, 17[A61K, G01N, C07K]
9517276 Compositions and methods for conjugating activatable antibodiesJun 04, 14Dec 13, 16[A61K, C07K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2013/0309,230 Modified Antibody Compositions, Methods of Making and Using ThereofAbandonedMar 04, 13Nov 21, 13[C07K]
2010/0189,651 MODIFIED ANTIBODY COMPOSITIONS, METHODS OF MAKING AND USING THEREOFAbandonedJan 12, 10Jul 29, 10[A61K, A61P, C07K]
2009/0304,719 ACTIVATABLE BINDING POLYPEPTIDES AND METHODS OF IDENTIFICATION AND USE THEREOFAbandonedAug 21, 08Dec 10, 09[A61K, C12P, C12N, G01N, C40B, C07K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.